masimo corp. - MASI

MASI

Close Chg Chg %
178.69 -0.60 -0.34%

Closed Market

178.09

-0.60 (0.34%)

Volume: 1.02M

Last Updated:

Mar 25, 2026, 4:00 PM EDT

Company Overview: masimo corp. - MASI

MASI Key Data

Open

$178.65

Day Range

178.01 - 178.77

52 Week Range

125.94 - 179.00

Market Cap

$9.33B

Shares Outstanding

52.20M

Public Float

49.25M

Beta

1.21

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$2.76

Yield

0.00%

Dividend

$1.00

EX-DIVIDEND DATE

Nov 23, 2012

SHORT INTEREST

N/A

AVERAGE VOLUME

2.03M

 

MASI Performance

1 Week
 
-0.08%
 
1 Month
 
1.56%
 
3 Months
 
34.14%
 
1 Year
 
8.89%
 
5 Years
 
-22.39%
 

MASI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About masimo corp. - MASI

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. It operates through the following segments: Healthcare and Non-Healthcare. The Healthcare segment develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation solutions and therapeutics. The Non-Healthcare segment designs, develops, manufactures, markets and sells a broad portfolio of premium, high-performance audio products and services. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

MASI At a Glance

Masimo Corp.
52 Discovery
Irvine, California 92618
Phone 1-949-297-7000 Revenue 1.53B
Industry Medical Specialties Net Income -151,500,000.00
Sector Health Technology Employees 7,500
Fiscal Year-end 12 / 2026
View SEC Filings

MASI Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 4.472
Price to Book Ratio 9.203
Price to Cash Flow Ratio 31.35
Enterprise Value to EBITDA 20.579
Enterprise Value to Sales 4.739
Total Debt to Enterprise Value 0.077

MASI Efficiency

Revenue/Employee 203,586.667
Income Per Employee -20,200.00
Receivables Turnover 4.662
Total Asset Turnover 0.706

MASI Liquidity

Current Ratio 2.492
Quick Ratio 1.469
Cash Ratio 0.41

MASI Profitability

Gross Margin 61.903
Operating Margin 20.486
Pretax Margin 17.853
Net Margin -9.922
Return on Assets 9.606
Return on Equity 23.428
Return on Total Capital 16.22
Return on Invested Capital 13.377

MASI Capital Structure

Total Debt to Total Equity 77.551
Total Debt to Total Capital 43.678
Total Debt to Total Assets 32.921
Long-Term Debt to Equity 75.555
Long-Term Debt to Total Capital 42.554
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Masimo Corp. - MASI

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
2.04B 2.05B 2.09B 1.53B
Sales Growth
+64.29% +0.60% +2.26% -27.10%
Cost of Goods Sold (COGS) incl D&A
977.00M 1.04B 1.09B 581.70M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
136.10M 98.30M 103.00M 38.80M
Depreciation
96.30M 43.90M 41.30M 25.50M
Amortization of Intangibles
39.80M 54.40M 61.70M 13.30M
COGS Growth
+126.78% +6.92% +4.35% -46.63%
Gross Income
1.06B 1.00B 1.00B 945.20M
Gross Income Growth
+30.98% -5.22% +0.09% -5.89%
Gross Profit Margin
+52.01% +49.00% +47.96% +61.90%
2022 2023 2024 2025 5-year trend
SG&A Expense
832.20M 839.20M 966.60M 632.40M
Research & Development
191.40M 175.20M 222.80M 126.40M
Other SG&A
640.80M 664.00M 743.80M 506.00M
SGA Growth
+56.27% +0.84% +15.18% -34.57%
Other Operating Expense
- - - -
-
Unusual Expense
16.60M 27.80M 304.50M 2.80M
EBIT after Unusual Expense
210.00M 136.50M (266.70M) 310.00M
Non Operating Income/Expense
9.10M 1.90M 5.00M (4.20M)
Non-Operating Interest Income
1.80M 3.00M 4.80M 3.40M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
25.70M 50.30M 43.60M 33.20M
Interest Expense Growth
+7,139.44% +95.72% -13.32% -23.85%
Gross Interest Expense
25.70M 50.30M 43.60M 33.20M
Interest Capitalized
- - - -
-
Pretax Income
193.40M 88.10M (305.30M) 272.60M
Pretax Income Growth
-29.51% -54.45% -446.54% +189.29%
Pretax Margin
+9.50% +4.30% -14.58% +17.85%
Income Tax
49.90M 6.60M (400.00K) 64.90M
Income Tax - Current - Domestic
54.80M 18.50M 18.40M 27.60M
Income Tax - Current - Foreign
34.40M 23.70M 19.40M 25.50M
Income Tax - Deferred - Domestic
(29.20M) (21.50M) (27.30M) 12.50M
Income Tax - Deferred - Foreign
(10.10M) (14.10M) (10.90M) (700.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
143.50M 81.50M (304.90M) 207.70M
Minority Interest Expense
- - - -
-
Net Income
143.50M 81.50M (304.90M) 207.70M
Net Income Growth
-37.51% -43.21% -474.11% +168.12%
Net Margin Growth
+7.05% +3.98% -14.56% +13.60%
Extraordinaries & Discontinued Operations
- - - (359.20M)
-
Discontinued Operations
- - - (359.20M)
-
Net Income After Extraordinaries
143.50M 81.50M (304.90M) (151.50M)
Preferred Dividends
- - - -
-
Net Income Available to Common
143.50M 81.50M (304.90M) (151.50M)
EPS (Basic)
2.6772 1.5436 -5.7204 -2.8265
EPS (Basic) Growth
-35.69% -42.34% -470.59% +50.59%
Basic Shares Outstanding
53.60M 52.80M 53.30M 53.60M
EPS (Diluted)
2.5996 1.5065 -5.7204 -2.8265
EPS (Diluted) Growth
-34.70% -42.05% -479.71% +50.59%
Diluted Shares Outstanding
55.20M 54.10M 53.30M 53.60M
EBITDA
362.70M 262.60M 140.80M 351.60M
EBITDA Growth
+16.27% -27.60% -46.38% +149.72%
EBITDA Margin
+17.82% +12.82% +6.72% +23.03%

Snapshot

Average Recommendation HOLD Average Target Price 178.60
Number of Ratings 7 Current Quarters Estimate 1.444
FY Report Date 03 / 2026 Current Year's Estimate 5.911
Last Quarter’s Earnings -0.18 Median PE on CY Estimate N/A
Year Ago Earnings 3.83 Next Fiscal Year Estimate 6.659
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 7 6
Mean Estimate 1.44 1.39 5.91 6.66
High Estimates 1.53 1.46 6.21 7.08
Low Estimate 1.38 1.18 5.72 6.28
Coefficient of Variance 3.42 6.91 2.75 4.89

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 5
OVERWEIGHT 1 3 3
HOLD 6 7 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Overweight

Insider Actions for Masimo Corp. - MASI

Date Name Shares Transaction Value
Mar 5, 2026 Micah Young EVP & Chief Financial Officer 33,347 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 5, 2026 Micah Young EVP & Chief Financial Officer 25,254 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $175.35 per share 4,428,288.90
Mar 5, 2026 Micah Young EVP & Chief Financial Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 13, 2025 William R. Jellison Director 4,790 Open market or private purchase of non-derivative security Non-derivative transaction at $145.98 per share 699,244.20

Masimo Corp. in the News